Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Anaplastic lymphoma kinase (ALK), also known as CD246, is a receptor tyrosine kinase and member of the insulin receptor superfamily.1 It is composed of an N-terminal extracellular domain that participates in cell-cell interactions, as well as transmembrane and juxtamembrane domains, and a C-terminal intracellular region that contains the protein kinase domain. Full-length ALK is expressed primarily in the embryonic nervous system, but the ALK kinase domain is expressed in a variety of cell types in the adult as a fusion protein.1,2 ALK is involved in cell proliferation and survival through downstream activation of the ERK1/2 and JAK/STAT signaling pathways, respectively.1 The fusion protein nucleophosmin-ALK (NPM-ALK) has a constitutively active ALK kinase domain and is ectopically expressed in anaplastic large-cell lymphoma (ALCL), a type of non-Hodgkin lymphoma.3 A variety of ALK-based fusion proteins are associated with ALCL, non-small cell lung cancer (NSCLC), inflammatory myofibroblastic tumor (IMT), diffuse large B cell lymphoma (DLBCL), and other cancers.1 Activating mutations in, and overexpression of, ALK have been associated with childhood neuroblastomas. Cayman’s ALK/CD246 (C-Term) Rabbit Monoclonal Antibody (Clone RM361) can be used for immunohistochemistry (IHC) and Western blot (WB) applications.
WARNING This product is not for human or veterinary use.
1. Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition. Pharmacol. Res. 68(1), 68-94 (2013).
2. Characterization of the expression of the ALK receptor tyrosine kinase in mice. Gene Expr. Patterns 6(5), 448-461 (2006).
3. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-